Renvela ® (sevelamer carbonate) is used to control phosphorus levels in adults and children 6 years of age and older with chronic kidney disease (CKD) on dialysis.

Mar 1, 2024 · Renvela (sevelamer) reduces blood levels of phosphorus in people with chronic kidney disease who are on dialysis. Includes Renvela side effects, interactions and indications.

Jun 20, 2023 · Renvela (sevelamer carbonate) is a phosphate binder indicated for the control of serum phosphorus in adults and children 6 years of age and older with chronic kidney disease on dialysis.

Renvela® is a phosphate binder indicated for the control of serum phosphorus in adults and children 6 years of age and older with chronic kidney disease on dialysis.

Feb 1, 2025 · Sevelamer is used to treat hyperphosphatemia (too much phosphate in the blood) in patients with chronic kidney disease who are on dialysis. This medicine is available only with your …

Mar 20, 2024 · How is sevelamer supplied (dosage forms)? Sevelamer is available as Renagel, Renvela, and generic sevelamer in the following dosage forms that are taken by mouth.

Aug 6, 2016 · Renvela (sevelamer carbonate) Tablet, Film Coated ... Renvela® (sevelamer carbonate) is indicated for the control of serum phosphorus in patients with chronic kidney disease (CKD) on …

Renvela® (sevelamer carbonate) is indicated for the control of serum phosphorus in adults and children 6 years of age and older with chronic kidney disease (CKD) on dialysis.

Nov 27, 2025 · Sevelamer helps prevent hypocalcemia (low levels of calcium in the body) caused by elevated phosphorus. Sevelamer is used to control phosphorus levels in people with chronic kidney …

Renvela contains sevelamer, a non-absorbed phosphate binding crosslinked polymer, free of metal and calcium. Sevelamer contains multiple amines separated by one carbon from the polymer backbone …